Skip to main content

Table 1 Patient demographics

From: Late-day intraocular pressure–lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial

 

Per-protocol population

Demographic

(n = 81)

Age

 

 Mean ± SD, y

58.3 ± 11.4

Race, n (%)

 

 Black

50 (62)

 White

28 (34)

 Asian

3 (4)

Sex, n (%)

 

 Male

27 (33)

 Female

54 (67)